Honduras screening starts Latin American rotavirus plan
This article was originally published in Clinica
Executive Summary
The Central American state of Honduras is to screen all children under the age of five years who present with gastroenteritis symptoms, in a bid to assess the incidence of the disease. Under an agreement signed in Tegucigalpa with an international support group that includes the Pan American Health Organization (PAHO), the US Centers for Disease Control and Prevention (CDC) and the Program for Appropriate Technology in Health (PATH), the health ministry will use the data to consider introducing a vaccination programme.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.